Artisan Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Artisan Partners’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-71,710	Closed	-$6.48M	–	374
2014 Q4	$6.48M	Sell	71,710 -70,531	-50%	-$5.87M	0.01%	330
2014 Q3	$10.3M	Buy	142,241 +72,597	+104%	+$4.77M	0.02%	316
2014 Q2	$4.33M	Buy	69,644 +3,945	+6%	+$238K	0.01%	337
2014 Q1	$4.48M	Buy	+65,699	New	+$4.84M	0.01%	331
2013 Q3	–	Sell	-10,800	Closed	-$603K	–	355
2013 Q2	$603K	Buy	+10,800	New	+$673K	﹤0.01%	366

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Artisan Partners's BMRN Position: Q1 2015 in Review

Artisan Partners sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2015, closing a stake of 71,710 shares — an estimated $6.48M sold.

Artisan Partners first reported a position in BMRN in Q2 2013 and held it in 5 quarters. The position peaked at $10.3M in Q3 2014. 378 funds tracked by Wall St. Rank hold BMRN as of Q1 2015.

Artisan Partners reported no remaining BioMarin Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Artisan Partners sold 71,710 BioMarin Pharmaceuticals shares in Q1 2015, an estimated $6.48M.
Artisan Partners first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Artisan Partners's BioMarin Pharmaceuticals position peaked at $10.3M in Q3 2014.
378 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2015.

Based on Artisan Partners's 13F filing for Q1 2015, filed 13 May 2015.